Capricorn Investment Group

SPAN

San Francisco

Enabling electrification for all ⚡

TrueCar

Santa Monica

TrueCar is an information and technology platform that enables its users to communicate with TrueCar certified dealers.

Rhoda AI

Palo Alto

Rhoda AI develops general-purpose robots powered by frontier AI models for real-world tasks in logistics, manufacturing, and beyond; backed by over $225 million from top-tier investors and building a world-class team to advance technology a

Heron Power

Scotts Valley

Heron Power develops scalable, low-cost power electronics and software-integrated infrastructure for the 21st-century grid, aiming to debottleneck growth in electricity generation and consumption and accelerate electrification with purpose-

Navitas Semiconductor

Torrance

Navitas Semiconductor develops a range of GaN power ICs for the power supply markets.

Harbinger

Garden Grove

Harbinger is a commercial electric vehicle company that focuses on chassis architecture design.

Heartflow

San Francisco

Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. With over 400,000 patients treated, more than 1,400 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in Mountain View, California, with additional offices in California, Texas, the UK and Japan. We believe CAD shouldn’t be a silent threat. We’re changing the story of CAD by making it screenable, diagnosable, and manageable — empowering clinicians to save lives and giving patients more time for what matters most.